Mother left infertile by cancer treatment gives birth after ovarian tissue graft and IVF

Evie is a miracle baby. Her Victorian mother Jodie Wyers, left infertile after cancer treatment, is the second woman in the world to give birth after ovarian tissue was grafted into her abdomen.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news

Related Links:

Small higher risk of non-invasive breast and ovarian tumours may not be due to treatment Related items fromOnMedica Only a third of women with regular bloating would see their GP Infertility much more likely after childhood cancer Unprotected sex among British teens – soars Experts call for wider HPV vaccination Use of contraceptive pill may lead to longer life
Source: OnMedica Latest News - Category: UK Health Source Type: news
Authors: Anderson RC, Newton CL, Anderson RA, Millar RP Abstract The gonadotropin receptors, luteinising hormone receptor, and follicle-stimulating hormone receptor, play a central role in governing reproductive competency/fertility. Gonadotropin hormone analogues have been utilised clinically for decades, in assisted reproductive therapies, and in the treatment of various infertility disorders. While these treatments are effective, the clinical protocols demand multiple injections, and the hormone preparations can lack uniformity and stability. The past two decades have seen a drive to develop chimeric and modifie...
Source: Endocrine Reviews - Category: Endocrinology Tags: Endocr Rev Source Type: research
Publication date: Available online 28 June 2018Source: Best Practice &Research Clinical Obstetrics &GynaecologyAuthor(s): Wanyuan Cui, Kelly-Anne PhillipsAbstractGlobally, breast cancer is the most common female reproductive cancer. Although not part of initial curative-intent treatment in women with other reproductive cancers, alkylating chemotherapy is often used to treat women with curable breast cancer. Chemotherapy-associated ovarian failure (COF) is a potential consequence of this treatment, and can cause infertility and increase the risk of cognitive impairment, cardiovascular disease and fractures from redu...
Source: Best Practice and Research Clinical Obstetrics and Gynaecology - Category: OBGYN Source Type: research
Fertility drugs don't increase a woman's chance of getting ovarian cancer, but infertility itself is associated with an increased risk, a new study suggests.
Source: WebMD Health - Category: Consumer Health News Source Type: news
FRIDAY, July 6, 2018 -- Fertility drugs do not increase a woman's risk of ovarian cancer, a new study suggests. It did find that infertility itself is associated with an increased risk of ovarian cancer. The researchers examined data from more than...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news
Publication date: Available online 28 June 2018Source: Best Practice &Research Clinical Obstetrics &GynaecologyAuthor(s): Wanyuan Cui, Kelly-Anne PhillipsAbstractGlobally, breast cancer is the most common female reproductive cancer. Although not part of initial curative-intent treatment in women with other reproductive cancers, alkylating chemotherapy is often used to treat women with curable breast cancer. Chemotherapy-associated ovarian failure (COF) is a potential consequence of this treatment, and can cause infertility and increase the risk of cognitive impairment, cardiovascular disease and fractures from redu...
Source: Best Practice and Research Clinical Obstetrics and Gynaecology - Category: OBGYN Source Type: research
Many survivors of childhood cancer will experience premature gonadal insufficiency or infertility as a consequence of their medical treatments. Ovarian tissue cryopreservation (OTC) remains an experimental means of fertility preservation with few reports focused on the surgical technique and postoperative outcomes for OTC in children.
Source: Journal of Pediatric Surgery - Category: Surgery Authors: Source Type: research
Source: Cancercompass News: Gynecological Cancer - Category: Cancer & Oncology Source Type: news
ConclusionAs a result, our data suggest that induction of HDAC6 levels by miR-762 suppression may improve the current protocol for OV.
Source: Journal of Assisted Reproduction and Genetics - Category: Reproduction Medicine Source Type: research
ConclusionThis study is at the best of our knowledge the first nationwide survey to assess the state of the art in oncofertility management. It highlights inadequate management of fertility preservation for female patients in France. Physicians reported lacking knowledge and tools that would allow them to provide patients with appropriate information. A better collaboration between cancer and fertility centers needs to be organized in France as already organized in other countries.
Source: Journal of Assisted Reproduction and Genetics - Category: Reproduction Medicine Source Type: research
More News: Babies | Cancer | Cancer & Oncology | Health | Infertility | Ovarian Cancer | Ovaries | Reproduction Medicine